MARINA DEL REY, Calif. and WALTHAM, Mass. – Heritage Development Organization, an affiliate of Heritage Provider Network (HPN), a national leader in coordinated care and integrated delivery network development and Fresenius Medical Care (NYSE: FMS), a diversified health care company and North America’s largest provider of kidney care and hospitalist services, announced an agreement today to develop physician networks and care coordination and population health management services in select markets throughout the country. The collaboration expands the two companies’ successful partnership with shared savings models and furthers their commitment to improving value in health care, making coordinated, value-based care more accessible to all Americans.
”Heritage Provider Network has a long history of providing high-quality, cost-effective coordinated care for large populations,” said Dr. Richard Merkin, President and CEO of Heritage Provider Network. “We are excited to expand our partnership with Fresenius Medical Care to bring their deep expertise in caring for people with complex chronic diseases, such as kidney failure, to our coordinated care networks. By combining the financial strength and specialized resources of Fresenius with the care coordination expertise of Heritage, we can improve patient outcomes and expand our ability to develop alternative payment models that will reduce costs for the communities we serve. We see this partnership as a model for how health care should be delivered in the United States.”
The collaboration aims for Heritage Provider Network to acquire or build coordinated care networks in markets across the country that will partner with Fresenius Medical Care, which will provide a variety of services including renal, vascular and hospitalist services to covered members. Through these coordinated networks, the organizations will seek to expand value-based contracting models with payors and jointly sponsor research initiatives to drive clinical innovation forward.
“Our overarching objective is to improve the quality of life and clinical outcomes for people with chronic conditions such as end stage renal disease,” said Ron Kuerbitz, CEO of Fresenius Medical Care North America. “By collaborating with a premier provider of high quality, patient-centered health care such as Heritage Provider Network, we believe we can better serve the patients and communities who put their trust in us and reduce costs for the entire health care system.”
About Heritage Provider Network
Heritage Provider Network, Inc. (HPN) is on the cutting edge of the accountable care model of healthcare delivery: coordinated, patient-doctor centric, integrated health care systems that represent the future of health care in the United States. With more than 4,000 primary care physicians and 33,000 specialist physicians in 12 owned independent physicians associations (IPAs), the Heritage family of companies also include, 52 staff model medical group sites and hospice, home health and surgery center companies. HPN and its affiliates operate in California, New York and Arizona providing high quality, cost effective health care to over 1 million individuals and are dedicated to quality, affordable health care, and putting patients’ wellness first. (http://www.heritageprovidernetwork.com)
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care company focused on delivering the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, as well as the country’s largest practice of hospitalist and post-acute providers, Fresenius Medical Care provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s only vertically integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. (www.fmcna.com)